Synthesis, characterization, and bioactivities of dithiocarbazate-Schiff base ligands and their metal complexes

There is an urgent need to discover new drugs with novel mechanisms of action,higher activity and improved selectivity to address the severe challenge of multidrug resistance in treating bacterial infections and cancer. In view of this, Schiff bases derived from S-substituted dithiocarbazate and the...

Full description

Saved in:

Bibliographic Details
Main Author:	Low, May Lee
Format:	Thesis
Language:	English
Published:	2014
Subjects:	Metals Ligands
Online Access:	http://psasir.upm.edu.my/id/eprint/52086/1/FS%202014%202RR.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-upm-ir.52086
record_format	uketd_dc
spelling	my-upm-ir.520862017-05-11T05:35:00Z Synthesis, characterization, and bioactivities of dithiocarbazate-Schiff base ligands and their metal complexes 2014-07 Low, May Lee There is an urgent need to discover new drugs with novel mechanisms of action,higher activity and improved selectivity to address the severe challenge of multidrug resistance in treating bacterial infections and cancer. In view of this, Schiff bases derived from S-substituted dithiocarbazate and their corresponding metal complexes with a plethora of potentially exciting biological activities and coordination chemistry are attractive candidates for consideration. Macroacyclic and open chain metal complexes with their respective tetradentate and bidentate nitrogen-sulphur (NS) Schiff base ligands derived from the condensation of S-benzyldithiocarbazate (SBDTC) and S-methyldithiocarbazate (SMDTC) with 2,5-hexanedione, methyl levulinate, levulinic acid, 4-carboxybenzaldehyde and 3- acetylcoumarin have been prepared. The compounds were fully characterized with various physico-chemical and spectroscopic methods. A total of 11 crystal structures were determined throughout this work. In order to provide more insight into the behaviour of the complexes in solution, electron paramagnetic resonance (EPR) and cyclic voltammetry (CV) experiments were performed. Conjugation of the most promising antimicrobial compound (Schiff base of SBDTC with 4-carboxybenzaldehyde) to various vectors (polyarginine, oligoethylene glycol (OEG) and phenylalanine-arginine-β-napthylamide (PAβN)) was achieved using either standard solid phase or solution synthetic methodologies to prepare improved therapeutic agents. Among the conjugates, the nonaarginine (R9) derivatives showed the most encouraging synergistic effect upon conjugation and complexation to copper ion with enhanced water solubility, bacteria cell membrane permeability and bioactivity. The Cu(II) R9 derivatives possess remarkable antibacterial activity against a wide spectrum of bacteria and in particular, highly efficacious against Staphylococcus aureus with MIC values up to 1-0.5 μM when tested against nine strains of Gram-positive and Gram-negative bacteria. This appears to be the pioneer study to show that the conjugation of polyarginine to dithiocarbazate compounds can greatly influence their therapeutic potential. Cytotoxic assay was also carried out for selected non-conjugated compounds. All the selected Cu(II) complexes assayed against breast cancer cells lines (MCF-7 and MDA-MB-231) exhibited good cytotoxicity with lower IC50 values (0.71-8.31 μM) in comparison to their respective ligands. This work highlights the relevance of metal complexation strategy to stabilize the ligands and improve their bioactivity. The structure-activity relationships of the compounds are discussed. Metals Ligands 2014-07 Thesis http://psasir.upm.edu.my/id/eprint/52086/ http://psasir.upm.edu.my/id/eprint/52086/1/FS%202014%202RR.pdf application/pdf en public phd doctoral Universiti Putra Malaysia Metals Ligands
institution	Universiti Putra Malaysia
collection	PSAS Institutional Repository
language	English
topic	Metals Ligands
spellingShingle	Metals Ligands Low, May Lee Synthesis, characterization, and bioactivities of dithiocarbazate-Schiff base ligands and their metal complexes
description	There is an urgent need to discover new drugs with novel mechanisms of action,higher activity and improved selectivity to address the severe challenge of multidrug resistance in treating bacterial infections and cancer. In view of this, Schiff bases derived from S-substituted dithiocarbazate and their corresponding metal complexes with a plethora of potentially exciting biological activities and coordination chemistry are attractive candidates for consideration. Macroacyclic and open chain metal complexes with their respective tetradentate and bidentate nitrogen-sulphur (NS) Schiff base ligands derived from the condensation of S-benzyldithiocarbazate (SBDTC) and S-methyldithiocarbazate (SMDTC) with 2,5-hexanedione, methyl levulinate, levulinic acid, 4-carboxybenzaldehyde and 3- acetylcoumarin have been prepared. The compounds were fully characterized with various physico-chemical and spectroscopic methods. A total of 11 crystal structures were determined throughout this work. In order to provide more insight into the behaviour of the complexes in solution, electron paramagnetic resonance (EPR) and cyclic voltammetry (CV) experiments were performed. Conjugation of the most promising antimicrobial compound (Schiff base of SBDTC with 4-carboxybenzaldehyde) to various vectors (polyarginine, oligoethylene glycol (OEG) and phenylalanine-arginine-β-napthylamide (PAβN)) was achieved using either standard solid phase or solution synthetic methodologies to prepare improved therapeutic agents. Among the conjugates, the nonaarginine (R9) derivatives showed the most encouraging synergistic effect upon conjugation and complexation to copper ion with enhanced water solubility, bacteria cell membrane permeability and bioactivity. The Cu(II) R9 derivatives possess remarkable antibacterial activity against a wide spectrum of bacteria and in particular, highly efficacious against Staphylococcus aureus with MIC values up to 1-0.5 μM when tested against nine strains of Gram-positive and Gram-negative bacteria. This appears to be the pioneer study to show that the conjugation of polyarginine to dithiocarbazate compounds can greatly influence their therapeutic potential. Cytotoxic assay was also carried out for selected non-conjugated compounds. All the selected Cu(II) complexes assayed against breast cancer cells lines (MCF-7 and MDA-MB-231) exhibited good cytotoxicity with lower IC50 values (0.71-8.31 μM) in comparison to their respective ligands. This work highlights the relevance of metal complexation strategy to stabilize the ligands and improve their bioactivity. The structure-activity relationships of the compounds are discussed.
format	Thesis
qualification_name	Doctor of Philosophy (PhD.)
qualification_level	Doctorate
author	Low, May Lee
author_facet	Low, May Lee
author_sort	Low, May Lee
title	Synthesis, characterization, and bioactivities of dithiocarbazate-Schiff base ligands and their metal complexes
title_short	Synthesis, characterization, and bioactivities of dithiocarbazate-Schiff base ligands and their metal complexes
title_full	Synthesis, characterization, and bioactivities of dithiocarbazate-Schiff base ligands and their metal complexes
title_fullStr	Synthesis, characterization, and bioactivities of dithiocarbazate-Schiff base ligands and their metal complexes
title_full_unstemmed	Synthesis, characterization, and bioactivities of dithiocarbazate-Schiff base ligands and their metal complexes
title_sort	synthesis, characterization, and bioactivities of dithiocarbazate-schiff base ligands and their metal complexes
granting_institution	Universiti Putra Malaysia
publishDate	2014
url	http://psasir.upm.edu.my/id/eprint/52086/1/FS%202014%202RR.pdf
_version_	1747812089503678464

Synthesis, characterization, and bioactivities of dithiocarbazate-Schiff base ligands and their metal complexes

Similar Items